Vaccines and Immunotherapy Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
PeerJ. 2023 Apr 11;11:e15024. doi: 10.7717/peerj.15024. eCollection 2023.
Misdiagnosing suspected COVID-19 individuals could largely contribute to the viruses transmission, therefore, making an accurate diagnosis of infected subjects vital in minimizing and containing the disease. Although RT-PCR is the standard method in detecting COVID-19, it is associated with some limitations, including possible false negative results. Therefore, serological testing has been suggested as a complement assay to RT-PCR to support the diagnosis of acute infections. In this study, 15 out of 639 unvaccinated healthcare workers (HCWs) were tested negative for COVID-19 by RT-PCR and were found seropositive for SARS-CoV-2 nucleocapsid protein-specific IgM and IgG antibodies. These participants underwent additional confirmatory RT-PCR and SARS-CoV-2 spike-specific ELISA tests. Of the 15 individuals, nine participants were found negative by second RT-PCR but seropositive for anti-spike IgM and IgG antibodies and neutralizing antibodies confirming their acute infection. At the time of collection, these nine individuals were in close contact with COVID-19-confirmed patients, with 77.7% reporting COVID-19-related symptoms. These results indicate that including serological tests in the current testing profile can provide better outcomes and help contain the spread of the virus by increasing diagnostic accuracy to prevent future outbreaks rapidly.
误诊疑似 COVID-19 个体可能在很大程度上导致病毒传播,因此,对感染个体进行准确诊断对于最大限度地减少和控制疾病至关重要。虽然 RT-PCR 是检测 COVID-19 的标准方法,但它存在一些局限性,包括可能出现假阴性结果。因此,血清学检测已被建议作为 RT-PCR 的补充检测方法,以支持急性感染的诊断。在这项研究中,639 名未接种疫苗的医护人员(HCWs)中有 15 名经 RT-PCR 检测为 COVID-19 阴性,但 SARS-CoV-2 核衣壳蛋白特异性 IgM 和 IgG 抗体呈血清阳性。这些参与者接受了额外的确认性 RT-PCR 和 SARS-CoV-2 刺突特异性 ELISA 检测。在这 15 个人中,有 9 名参与者的第二次 RT-PCR 结果为阴性,但血清对刺突 IgM 和 IgG 抗体以及中和抗体呈阳性,证实他们发生了急性感染。在采集样本时,这 9 名个体与 COVID-19 确诊患者密切接触,77.7%的个体报告了 COVID-19 相关症状。这些结果表明,在当前的检测方案中纳入血清学检测可以提供更好的结果,并通过提高诊断准确性来帮助控制病毒的传播,从而迅速防止未来的爆发。